CBD Professional Literature

Welcome you to our continuously growing library of CBD articles and world-wide published studies.

Here you can find vast information about the CBD and its effect on our health in so many aspects.

Alzheimer's Disease

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease.

Antiemetic

Regulation of nausea and vomiting by cannabinoids.

Asthma

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma.

Autism

A Novel Approach to the Symptomatic Treatment of Autism.

Brest Cancer

Antitumor Activity of Plant Cannabinoids with Emphasis on the effect of Cannabidiol on Human Breast Carcinoma.

Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy.

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.

Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells.

Cannabidiol inhibits angiogenesis by multiple mechanisms.

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.

Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1

Cannabidiol as potentialanticancer drug.

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy.

Cannabinoids as therapeutic agents in cancer-current status and future implications.

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.

Cancer General

A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.

The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors.

Cannabinoids as therapeutic agents in cancer: current status and future implications.

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.

Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8.

Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.

Cardiovascular

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusionb.

Dermatology-Psoriasis

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.

Sebocytes Express Functional Cathelicidin Antimicrobial Peptides and Can Act to Kill Propionibacterium Acnes.

Cannabinoid system in the skin – a possible target for future therapies in dermatology.

Evidence that the plant cannabinoid cannabigerol is a highly potent a2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.

Epilepsy

Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo.

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus.

GI cancer

Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent.

Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa.

Glioblastom-gliom

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.

Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87- MG and T98G Glioma Cells through a Multitarget Effect.

Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target.

Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.

Heapatic diseases

Cannabidiol causes activated hepatic stellate cell death.

Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol.

Involvement of PPARc in the antitumoral action of cannabinoids on hepatocellular carcinoma.

Endocannabinoids in Liver Disease.

Inflammatory diseases

Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis.

Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.

Cannabinoids suppress inflammatory and neuropathic pain by targeting 3 glycine receptors.

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation.

https://www.nutra-supp.com/wp-content/uploads/2019/07/Immunoactive-effects-of-cannabinoids-considerations-for-the-therapeutic-use-of-cannabinoid-receptor-agonists-and-antagonists.pdf.

Mucosal-Associated Invariant T Cell Is a Potential Marker to Distinguish Fibromyalgia Syndrome from Arthritis.

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Cannabidiol (CBD) and its analogs a review of their effects on inflammation.

Cannabidiol (CBD) Enhances Lipopolysaccharide (LPS)-Induced.

Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity.

CANNABIDIOL IS A SUBTYPE-SPECIFIC INHIBITOR OF INFLAMMATORY LIPOXYGENASE ENZYMES.

Leukemia

Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression.

Lung cancer

Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.

COX-2 and PPAR-g Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells.

Login